Clinical trials
Phase 2 Insulinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2020 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Terminated | 5 |
| Withdrawn | 4 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| ECOG-ACRIN Cancer Research Group | 2 |
| Eastern Cooperative Oncology Group | 2 |
| Academic and Community Cancer Research United | 1 |
| British Columbia Cancer Agency | 1 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
| Delcath Systems Inc. | 1 |
| Emory University | 1 |
| Federation Francophone de Cancerologie Digestive | 1 |
| Masonic Cancer Center, University of Minnesota | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Insulinoma | 22 |
| Glucagonoma | 19 |
| Somatostatinoma | 19 |
| Gastrinoma | 17 |
| Carcinoma, Islet Cell | 16 |
| Vipoma | 9 |
| Adenoma, Islet Cell | 7 |
| Neoplasms | 5 |
| Neuroendocrine Tumors | 3 |
| Pancreatic Neoplasms | 3 |
Trials
Showing 51 to 22 of 22. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.